Tag Archive | "Funding Partners"

New Industry Partner: Piramal

Piramal has become a PPMI industry partner. Industry partners are contributing to PPMI through financial and in-kind donations and are playing a lead role in providing feedback on study parameters through the Industry Scientific Advisory Board (ISAB). Through close interaction with the study, the ISAB is positioned to inform the selection and review of potential progression markers that could be used in clinical testing.

Continue reading...

Two new industry partners join PPMI

Bristol-Myers Squibb and Meso Scale Discovery have joined PPMI as industry partners. Industry partners are contributing to PPMI through financial and in-kind donations and are playing a lead role in providing feedback on study parameters through the Industry Scientific Advisory Board (ISAB). PPMI now has 15 industry partners.

Continue reading...

Summary of the PPMI 2013 Annual Meeting in New York, NY

The 2013 PPMI Annual Meeting took place on May 7th & 8th in New York, NY. Site investigators, study staff, industry partner representatives, patient advisory committee members, Study Core members, and members of the Steering Committee gathered for a holistic overview of what has already been accomplished and what the future holds for PPMI.

Continue reading...

Update on New Prodromal Cohort Added to PPMI

This March, the Parkinson?s Progression Markers Initiative (PPMI) will launch a new study arm to enroll and follow a prodromal Parkinson?s disease (PD) cohort.   Defining a pre-diagnostic or prodromal phase for PD presents both an immediate challenge ? how to reliably identify individuals during this prodromal period at high risk to phenoconvert to PD ? […]

Continue reading...

Share your thanks with PPMI study participants

Take a few minutes to write a letter of thanks to the PPMI participants who are making this study possible.

Continue reading...

Biomarkers for Brain Disorders Presentation on PPMI

Dr. Ken Marek, PPMI Study PI, will attend the Biomarkers for Brain Disorders meeting in Cambridge, UK on February 5, 2013.

Continue reading...

PPMI 2012 Annual Meeting Summary

The PPMI Annual Meeting recently took place in New York City. Access to the presentations that were made at the meeting are now available.

Continue reading...

PPMI 2011 Annual Meeting Summary

The PPMI Annual Meeting recently took place in New York City. Access to the presentations that were made at this event are now available.

Continue reading...

GE announces FDA approval of DaTscan

The FDA has approved DaTscan, an imaging technique that detects dopamine transporters in the brain, which can help to detect and diagnose disorders like PD. DaTscan is currently in use at all 21 PPMI clinical sites in the US and Europe.

Continue reading...

Dow Jones touts public-private partnership model of PPMI

MJFF co-founder Debi Brooks discusses the unique funding model being employed in PPMI. MJFF is past the halfway mark in efforts to secure $20m from pharma and biotech companies.

Continue reading...